Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 5 (2008), Issue 5 (May)

1. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
   Hum Mol Genet, 17(10): 1482-96. [Abstract] [Full-text]
2. The incidence and risk factors associated with postoperative delirium in geriatric patients undergoing surgery for suspected gynecologic malignancies.
   Gynecol Oncol, 109(2): 296-302. [Abstract] [Full-text]
3. MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease.
   J Neurochem, 105(5): 2039-52. [Abstract] [Full-text]
4. Parkin mediates the degradation-independent ubiquitination of Hsp70.
   J Neurochem, 105(5): 1806-19. [Abstract] [Full-text]
5. Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways.
   J Neurochem, 105(5): 1700-15. [Abstract] [Full-text]
6. Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.
   J Neurochem, 105(5): 1656-67. [Abstract] [Full-text]
7. Changes in quality of life in people with Parkinson's disease left untreated at diagnosis.
   J Neurol Neurosurg Psychiatry, 79(6): 716-8. [Abstract] [Full-text]
8. Effects of subthalamic deep brain stimulation on noun/verb generation and selection from competing alternatives in Parkinson's disease.
   J Neurol Neurosurg Psychiatry, 79(6): 700-5. [Abstract] [Full-text]
9. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism.
   J Neurol Neurosurg Psychiatry, 79(6): 652-5. [Abstract] [Full-text]
10. Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain.
    Neurology, 70(21): 1996-2003. [Abstract] [Full-text]
11. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.
    Neurology, 70(21): 1980-3. [Abstract] [Full-text]
12. Total cholesterol and the risk of Parkinson disease.
    Neurology, 70(21): 1972-9. [Abstract] [Full-text]
13. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease.
    J Neurosci, 28(21): 5504-12. [Abstract] [Full-text]
14. Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.
    Neurobiol Aging, 29(7): 1027-39. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.